Sandra Bien
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
- PARP inhibition in cancer therapy
Papers in
-
- Cell death mechanisms and regulation 2
- Oncology 5
- Drug Transport and Resistance Mechanisms 4
- Cancer Treatment and Pharmacology 1
- Co-authors
- Heyo K. Kroemer (13 shared papers)Carsten Tschöpe (4 shared papers)Alexander Riad (4 shared papers)Heinz‐Peter Schultheiß (2 shared papers)Dirk Westermann (2 shared papers)Stephan B. Felix (3 shared papers)Thomas Krieg (2 shared papers)Matthias Gratz (2 shared papers)
- Journals
- Cancer Research (2 papers)Journal of Pharmaceutical Sciences (1 paper)Drug Metabolism and Disposition (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)Pharmacogenetics and Genomics (1 paper)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
Sandra Bien
14 papers receiving 711 citations
Peers
Comparison fields: 5 of 78
- Cardiology and Cardiovascular Medicine 367
- Oncology 310
- Biophysics 59
- Physiology 19
- Pathology and Forensic Medicine 66
Countries citing papers authored by Sandra Bien
This map shows the geographic impact of Sandra Bien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Bien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Bien more than expected).
Fields of papers citing papers by Sandra Bien
This network shows the impact of papers produced by Sandra Bien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Bien. The network helps show where Sandra Bien may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Bien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 164 | |
| 2 | 2008 | 148 | |
| 3 | 2002 | 89 | |
| 4 | 2007 | 88 | |
| 5 | 2009 | 54 | |
| 6 | 2009 | 38 | |
| 7 | 2004 | 36 | |
| 8 | 2010 | 28 | |
| 9 | 2010 | 24 | |
| 10 | 2011 | 18 | |
| 11 | 2007 | 15 | |
| 12 | 2012 | 8 | |
| 13 | 2007 | 7 | |
| 14 | 2004 | 5 |
About Sandra Bien
Sandra Bien is a scholar working on Molecular Biology, Oncology, Cardiology and Cardiovascular Medicine, Cancer Research and Infectious Diseases, having authored 14 papers that have together received 722 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Pharmacological Effects and Toxicity Studies (2 papers), Electron Spin Resonance Studies (2 papers), NF-κB Signaling Pathways (2 papers), Cell death mechanisms and regulation (2 papers), HIV/AIDS drug development and treatment (2 papers) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (367 citations), Oncology (310 citations), Biophysics (59 citations), Physiology (19 citations) and Pathology and Forensic Medicine (66 citations). Sandra Bien has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Heyo K. Kroemer, Carsten Tschöpe, Alexander Riad, Heinz‐Peter Schultheiß, Dirk Westermann, Stephan B. Felix, Thomas Krieg, Matthias Gratz, Komal Loya and Ulf Landmesser. Their work appears in journals such as Cancer Research, Journal of Pharmaceutical Sciences, Drug Metabolism and Disposition, Naunyn-Schmiedeberg s Archives of Pharmacology and Pharmacogenetics and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.